These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30822557)

  • 1. STAT3beta, a distinct isoform from STAT3.
    Zhang HX; Yang PL; Li EM; Xu LY
    Int J Biochem Cell Biol; 2019 May; 110():130-139. PubMed ID: 30822557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Opposing Function of STAT3 as an Oncoprotein and Tumor Suppressor Is Dictated by the Expression Status of STAT3β in Esophageal Squamous Cell Carcinoma.
    Zhang HF; Chen Y; Wu C; Wu ZY; Tweardy DJ; Alshareef A; Liao LD; Xue YJ; Wu JY; Chen B; Xu XE; Gopal K; Gupta N; Li EM; Xu LY; Lai R
    Clin Cancer Res; 2016 Feb; 22(3):691-703. PubMed ID: 26405196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective STAT3-α or -β expression reveals spliceform-specific phosphorylation kinetics, nuclear retention and distinct gene expression outcomes.
    Ng IH; Ng DC; Jans DA; Bogoyevitch MA
    Biochem J; 2012 Oct; 447(1):125-36. PubMed ID: 22799634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stat3 isoforms, alpha and beta, demonstrate distinct intracellular dynamics with prolonged nuclear retention of Stat3beta mapping to its unique C-terminal end.
    Huang Y; Qiu J; Dong S; Redell MS; Poli V; Mancini MA; Tweardy DJ
    J Biol Chem; 2007 Nov; 282(48):34958-67. PubMed ID: 17855361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Entinostat as a Novel Modifier of STAT3 Pre-mRNA Alternative Splicing.
    Kise M; Masaki S; Kataoka N; Suzuki K
    Biol Pharm Bull; 2024; 47(9):1504-1510. PubMed ID: 39284734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stat3 and G-CSF-induced myeloid differentiation.
    Chakraborty A; Tweardy DJ
    Leuk Lymphoma; 1998 Aug; 30(5-6):433-42. PubMed ID: 9711905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional differences between Stat3alpha and Stat3beta.
    Schaefer TS; Sanders LK; Park OK; Nathans D
    Mol Cell Biol; 1997 Sep; 17(9):5307-16. PubMed ID: 9271408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PCBP1 inhibits the expression of oncogenic STAT3 isoform by targeting alternative splicing of STAT3 exon 23.
    Wang X; Guo J; Che X; Jia R
    Int J Biol Sci; 2019; 15(6):1177-1186. PubMed ID: 31223278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3 isoforms: Alternative fates in cancer?
    Aigner P; Just V; Stoiber D
    Cytokine; 2019 Jun; 118():27-34. PubMed ID: 30031681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumorigenic potential of STAT3 alternative splicing modulation.
    Zammarchi F; de Stanchina E; Bournazou E; Supakorndej T; Martires K; Riedel E; Corben AD; Bromberg JF; Cartegni L
    Proc Natl Acad Sci U S A; 2011 Oct; 108(43):17779-84. PubMed ID: 22006329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal Antibodies Specific for STAT3β Reveal Its Contribution to Constitutive STAT3 Phosphorylation in Breast Cancer.
    Bharadwaj U; Kasembeli MM; Eckols TK; Kolosov M; Lang P; Christensen K; Edwards DP; Tweardy DJ
    Cancers (Basel); 2014 Sep; 6(4):2012-34. PubMed ID: 25268166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel missense (M206K) STAT3 mutation in diffuse large B cell lymphoma deregulates STAT3 signaling.
    Hu G; Witzig TE; Gupta M
    PLoS One; 2013; 8(7):e67851. PubMed ID: 23861822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine-induced slowing of STAT3 nuclear import; faster basal trafficking of the STAT3β isoform.
    Ng IH; Bogoyevitch MA; Jans DA
    Traffic; 2014 Sep; 15(9):946-60. PubMed ID: 24903907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific ablation of Stat3beta distorts the pattern of Stat3-responsive gene expression and impairs recovery from endotoxic shock.
    Yoo JY; Huso DL; Nathans D; Desiderio S
    Cell; 2002 Feb; 108(3):331-44. PubMed ID: 11853668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT3 isoforms differentially affect ACE2 expression: A potential target for COVID-19 therapy.
    Shamir I; Abutbul-Amitai M; Abbas-Egbariya H; Pasmanik-Chor M; Paret G; Nevo-Caspi Y
    J Cell Mol Med; 2020 Nov; 24(21):12864-12868. PubMed ID: 32949179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT3β is a tumor suppressor in acute myeloid leukemia.
    Aigner P; Mizutani T; Horvath J; Eder T; Heber S; Lind K; Just V; Moll HP; Yeroslaviz A; Fischer MJM; Kenner L; Győrffy B; Sill H; Grebien F; Moriggl R; Casanova E; Stoiber D
    Blood Adv; 2019 Jul; 3(13):1989-2002. PubMed ID: 31270081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditional overexpression of Stat3alpha in differentiating myeloid cells results in neutrophil expansion and induces a distinct, antiapoptotic and pro-oncogenic gene expression pattern.
    Redell MS; Tsimelzon A; Hilsenbeck SG; Tweardy DJ
    J Leukoc Biol; 2007 Oct; 82(4):975-85. PubMed ID: 17634277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligonucleotide-directed STAT3 alternative splicing switch drives anti-tumorigenic outcomes in MCF10 human breast cancer cells.
    Tano V; Jans DA; Bogoyevitch MA
    Biochem Biophys Res Commun; 2019 Jun; 513(4):1076-1082. PubMed ID: 31010684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dimer stability as a determinant of differential DNA binding activity of Stat3 isoforms.
    Park OK; Schaefer LK; Wang W; Schaefer TS
    J Biol Chem; 2000 Oct; 275(41):32244-9. PubMed ID: 10915797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Of alphas and betas: distinct and overlapping functions of STAT3 isoforms.
    Dewilde S; Vercelli A; Chiarle R; Poli V
    Front Biosci; 2008 May; 13():6501-14. PubMed ID: 18508676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.